article thumbnail

Stanford University’s Innovative Medicines Accelerator and Intonation Research Laboratories form a collaboration to fight cancerous neuroendocrine tumors

SCIENMAG: Medicine & Health

Stanford University’s Innovative Medicines Accelerator (IMA) and Intonation Research Laboratories (Intonation) have formed a collaboration to develop treatments that target cancerous neuroendocrine tumors, or tumors that form from hormone-releasing cells.

article thumbnail

Merck continues to boost oncology pipeline through acquisitions

Drug Discovery World

“At Merck, we continue to enhance our oncology pipeline through strategic acquisitions that complement our current portfolio and advance breakthrough science to help address the needs of people with cancer worldwide,” said Dr Dean Li, President, Merck Research Laboratories.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck and Moderna to develop a personalised cancer vaccine

Drug Discovery World

“This long-term collaboration combining Merck’s expertise in immuno-oncology with Moderna’s pioneering mRNA technology has yielded a novel tailored vaccine approach,” said Dr Eliav Barr, Senior Vice President and Head of Global Clinical Development, Chief Medical Officer, Merck Research Laboratories. . “We

Vaccine 244
article thumbnail

Ginkgo Bioworks and Merck collaborate to improve biologic manufacturing 

Drug Discovery World

.” “At Merck, we are always seeking new and innovative ways to optimise process efficiency while maintaining product integrity,” said Dr Michael Kress, Senior Vice President, Development Sciences and Clinical Supply, Merck Research Laboratories. The post Ginkgo Bioworks and Merck collaborate to improve biologic manufacturing (..)

article thumbnail

Hybrid AI-powered computer vision combines physics and big data

SCIENMAG: Medicine & Health

Researchers from UCLA and the United States Army Research Laboratory have laid out a new approach to enhance artificial intelligence-powered computer vision technologies by adding physics-based awareness to data-driven techniques.

article thumbnail

IRBM and Merck extend peptide therapeutics collaboration

Drug Discovery World

“At MSD, we continue to evaluate the opportunities for peptide-based therapeutic candidates across multiple indications,” said Rob Garbaccio, Vice President, Head of Discovery Chemistry at MSD Research Laboratories. “We

article thumbnail

Johns Hopkins APL creates autonomy safety net for AFWERX Autonomy Prime Program

SCIENMAG: Medicine & Health

The Johns Hopkins Applied Physics Laboratory (APL) in Laurel, Maryland, is equipping AFWERX — a technology directorate of the Air Force Research Laboratory (AFRL) and the innovation arm of the Department of the Air Force — with capabilities to quickly and safely test autonomous vehicles in complex, interactive environments.